These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16173261)

  • 1. Haemorrhagic gastritis and bleeding following rofecoxib administration.
    Tuccori M; Martini G; Giustini SE; Salvetti A; Blandizzi C; Del Tacca M
    Clin Exp Rheumatol; 2005; 23(5):727-8. PubMed ID: 16173261
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe upper gastrointestinal bleeding during treatment with rofecoxib for osteoarthritis.
    Caroli A; Monica F
    Am J Gastroenterol; 2001 May; 96(5):1663-5. PubMed ID: 11374736
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points.
    Hawkey GM; Cole AT; McIntyre AS; Long RG; Hawkey CJ
    Gut; 2001 Sep; 49(3):372-9. PubMed ID: 11511559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lansoprazole-induced thrombocytopenia.
    Zlabek JA; Anderson CG
    Ann Pharmacother; 2002 May; 36(5):809-11. PubMed ID: 11978156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemic colitis associated with rofecoxib.
    Radaelli F; Feltri M; Meucci G; Spinzi G; Terruzzi V; Minoli G
    Dig Liver Dis; 2005 May; 37(5):372-6. PubMed ID: 15843089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why is this woman smiling? The hard sell of bad medicine.
    Bloice C
    Revolution (Oakl); 2005; 6(1):22-9. PubMed ID: 15822700
    [No Abstract]   [Full Text] [Related]  

  • 7. Patient empowerment: rofecoxib revisited.
    Tannenbaum H
    J Rheumatol; 2006 Jun; 33(6):1033-5. PubMed ID: 16755647
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rofecoxib-induced upper gastrointestinal bleeding].
    de La Serna Higuera C; Rodríguez-Gómez SJ; Martín Arribas MI; Martínez Moreno J
    Med Clin (Barc); 2002 Feb; 118(6):238; author reply 239. PubMed ID: 11864550
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse oral reactions associated with the COX-2 inhibitor rofecoxib.
    Bagán JV; Thongprasom K; Scully C
    Oral Dis; 2004 Nov; 10(6):401-3. PubMed ID: 15533219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
    Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons on prescribing and drug safety from the withdrawal of rofecoxib.
    Nelson M; Cicuttini F
    Aust Fam Physician; 2004 Dec; 33(12):965-6. PubMed ID: 15630913
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of cardiovascular events with coxibs and NSAIDs.
    Scott DG; Watts RA
    Lancet; 2005 Apr 30-May 6; 365(9470):1537. PubMed ID: 15866299
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gastro-intestinal toxicity of rofecoxib].
    Lima Rodríguez EM; Calvo Romero JM
    Aten Primaria; 2005 Feb; 35(2):110-1. PubMed ID: 15727757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients.
    Jhala NC; McFarland MM; Brightman SA; Morale B; Rubin W; Atkinson BF
    Am J Gastroenterol; 1995 Oct; 90(10):1824-8. PubMed ID: 7572902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug of the month. Lansoprazole (DakaR)].
    Scheen AJ
    Rev Med Liege; 1995 Mar; 50(3):133-4. PubMed ID: 7724943
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical effectiveness of lansoprazole in patients with gastric ulcers: evaluation of quality of ulcer healing based on endoscopic ultrasonographic findings.
    Obara K; Kuwana T; Ishihata R; Kondo Y; Ejiri Y; Yokogi K; Okubo Y; Ajima H; Mukai S; Kasukawa R
    J Clin Gastroenterol; 1995; 20 Suppl 2():S36-9. PubMed ID: 7594336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of omeprazole and placebo for bleeding peptic ulcer.
    Srinath C
    Trop Gastroenterol; 1997; 18(3):115-6. PubMed ID: 9385855
    [No Abstract]   [Full Text] [Related]  

  • 19. What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex).
    Wooltorton E
    CMAJ; 2002 Jun; 166(13):1692-3. PubMed ID: 12126328
    [No Abstract]   [Full Text] [Related]  

  • 20. [A clinical trial of lansoprazole in the treatment of duodenal ulcer].
    Pei Y; Wang B; Chen S
    Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):606-8. PubMed ID: 8697927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.